» Articles » PMID: 35743795

Ethical and Legal Aspects of Technology-Assisted Care in Neurodegenerative Disease

Overview
Journal J Pers Med
Date 2022 Jun 24
PMID 35743795
Authors
Affiliations
Soon will be listed here.
Abstract

Technological solutions are increasingly seen as a way to respond to the demands of managing complex chronic conditions, especially neurodegenerative diseases such as Parkinson's Disease. All of these new possibilities provide a variety of chances to improve the lives of affected persons and their families, friends, and caregivers. However, there are also a number of challenges that should be considered in order to safeguard the interests of affected persons. In this article, we discuss the ethical and legal considerations associated with the use of technology-assisted care in the context of neurodegenerative conditions.

Citing Articles

AI-Enhanced Healthcare: Not a new Paradigm for Informed Consent.

Pruski M J Bioeth Inq. 2024; 21(3):475-489.

PMID: 38300443 PMC: 11652578. DOI: 10.1007/s11673-023-10320-0.


Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment: the AI-Mind clinical study protocol.

Haraldsen I, Hatlestad-Hall C, Marra C, Renvall H, Maestu F, Acosta-Hernandez J Front Neurorobot. 2024; 17:1289406.

PMID: 38250599 PMC: 10796757. DOI: 10.3389/fnbot.2023.1289406.

References
1.
Lucivero F, Jongsma K . A mobile revolution for healthcare? Setting the agenda for bioethics. J Med Ethics. 2018; 44(10):685-689. PMC: 6173811. DOI: 10.1136/medethics-2017-104741. View

2.
Luis-Martinez R, Monje M, Antonini A, Sanchez-Ferro A, Mestre T . Technology-Enabled Care: Integrating Multidisciplinary Care in Parkinson's Disease Through Digital Technology. Front Neurol. 2020; 11:575975. PMC: 7673441. DOI: 10.3389/fneur.2020.575975. View

3.
Yuste R, Goering S, Aguera Y Arcas B, Bi G, Carmena J, Carter A . Four ethical priorities for neurotechnologies and AI. Nature. 2017; 551(7679):159-163. PMC: 8021272. DOI: 10.1038/551159a. View

4.
Merola A, Sturchio A, Hacker S, Serna S, Vizcarra J, Marsili L . Technology-based assessment of motor and nonmotor phenomena in Parkinson disease. Expert Rev Neurother. 2018; 18(11):825-845. DOI: 10.1080/14737175.2018.1530593. View

5.
Karlawish J, Cary M, Moelter S, Siderowf A, Sullo E, Xie S . Cognitive impairment and PD patients' capacity to consent to research. Neurology. 2013; 81(9):801-7. PMC: 3908465. DOI: 10.1212/WNL.0b013e3182a05ba5. View